Trial intelligence / Profile preview

Mirtazapine in young adults with comorbid AUD and MDD

NCT02646449Phase 2Completed

Sponsor
University of Pittsburgh
Start
Jun 2015
Primary completion
Dec 2016
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of mirtazapine in major depressive disorder (MDD), alcohol use disorder (AUD), sponsored by University of Pittsburgh. Started Jun 2015; status: completed.

02

Drugs

mirtazapine
03

Conditions

major depressive disorder (MDD)alcohol use disorder (AUD)

Beyond the preview

Go deeper on NCT02646449.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02646449.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call